Chronic urticaria/angioedema

Annals of Allergy, Asthma and Immunology

Volumn 85, Issue 6 II, 2000, Pages 532-544

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001371325     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1081-1206(10)62345-9     Document Type: Article

References (40)

1. Greaves MW. Chronic urticaria. N Engl J Med 1995;322:1767-1772.
2. Charlesworth EN. The spectrum of urticaria. In: Charlesworth EN, ed. Immunology and Allergy Clinics of North America 1995;15:641-657.
3. Mathews KP. Urticaria and angioedema. J Allergy Clin Immunol 1983; 72:1-14.
4. Kaplan AP. Urticaria and angioedema. In: Middleton E, Reed CE, Ellis EF, et al, eds. Allergy, principles and practice. 5th edition 1998: 1104-1122.
5. Wanderer AA. Urticaria and angioedema. In: Friedman HH, ed. Problem-oriented medical diagnosis. 4th edition 1987:29-33.
6. Venzor J, Baer SC, Huston DP. Urticarial vasculitis. In: Charlesworth EN, ed. In: Immunology and Allergy Clinics of North America 1995;15: 761-774.
7. Aboobaker J, Greaves MW. Urticarial vasculitis. Clin Exp Dermatol 1986;11:436-444.
8. McDuffie FC, Sams WM Jr, Maldano JE. Hypocomplementemia with cutaneous vasculitis and arthritis: possible immune complex syndrome. Mayo Clin Proc 1973;48:340-348.
9. Soter NA. Chronic urticaria as a manifestation of necrotizing venulitis. N Engl J Med 1977;296:1440-1442.
10. Sher T. Generalized pruritis in a 62 year old male. Ann Allergy 1990;64: 422-425.
11. Millar MM, Patterson R. A patient referred for evaluation of angioedema. Ann Allergy Asthma Immunol 1998;81:120-126.
12. Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor-associated angioedema. JAMA 1997;278:232-233.
13. Sussman GL, Tarlo S, Dolovich J. The spectrum of IgE-mediated responses to latex. 1991;265: 2844-2847.
14. Valentine MD. Allergy to stinging insects. Ann Allergy 1993;70:427-432.
15. Valentine MD. Insect venom allergy: diagnosis and treatment. J Allergy Clin Immunol 1984;73:299-304.
16. Wanderer AA. The spectrum of cold urticaria. In: Charlesworth EN, ed. Immunology and Allergy Clinics of North America 1995;15:701-723.
17. Sheffer AL, Austen KF. Exercise-induced anaphylaxis. J Allergy Clin Immunol 1980;66:106.
18. Volcheck GW, Li JTC. Exercise-induced urticaria and anaphylaxis. Mayo Clin Proc 1997;72:140-147.
19. Dover J, Black A, Ward A. Delayed pressure urticaria: clinical features, laboratory investigations and response to therapy of 44 patients. J Am Acad Dermatol 1988;18: 1289-1298.
20. Rance F, Kann G, Dutau G, Moneret-Vautrin DA. Food hypersensitivity in children: clinical aspects and distribution of allergens. Pediatr Allergy Immunol 1999;10:33-38.
21. Jarisch R, Beringer K, Hemer W. Role of food allergy and food intolerance in recurrent urticaria. Curr Prob Dermatol 199;28:64-73.
22. Castillo R, Delgado J, Quiralte J et al. Food hypersensitivity among adult patients: epidemiological and clinical aspects. Allergol Immunopathol 1996;24:93-97.
23. Lehach JG, Rosenstreich DL. Clinical aspects of chronic urticaria. 1992; 10:281-301.
24. Kaplan AP. Urticaria and angioedema. In: Middleton E, Reed CE, Ellis EF, et al, eds. Allergy, principles and 5th edition 1998;1113-1114.
25. Hara T, Shiotani A, Matsunaka H, et al. Hereditary angioedema with gastrointestinal involvement: endoscopic appearance. Endoscopy 1999;31: 322-324.
26. Shah TJ, Knowles WO, McGready SJ. Hereditary angioedema with recurrent abdominal pain and ascites. J Allergy Clin Immunol 1995;96: 259-261.
27. Cicardi M, Agostoni A. Hereditary angioedema. N Engl J Med 1996;334: 1630-1634.
28. Zahedi R, Aulak KS, Eldering E, Davis AE. Characterization of CI inhibitor-Ta. A dysfunctional C1INH with deletion of lysine 251. J Biol Chem 1996;271:24307-24312.
29. Cicardi M, Bergamaschini L, Cugno M, et al. Pathogenetic and clinical aspects of C1 inhibitor deficiency. Immunobiology 1998;199:366-376.
30. Valsecchi R, Reseghetti A, Pansera B, Di Landro A. Autoimmune C1 inhibitor deficiency and angioedema. Dermatology 1997;195:169-172.
31. Donaldson VH, Bernstein DI, Wagner CJ, et al. Angioneurotic edema with acquired C1 inhibitor deficiency and autoantibody to C1 inhibitor: response to plasmapheresis and cytotoxic therapy. J Lab Clin Med 1992; 119:397-406.
32. Norsworthy P, Theodorides E, Botto M, et al. Overrepresentation of the Fcgamma receptor type IIA R131/ R131 genotype in caucasoid SLE patients with autoantibodies to C1q and glomerulonephritis. Arthritis Rheum 1999;42:1828-1832.
33. Walport MJ, Davies KA, Botto M. C1q and SLE. Immunobiology. 1998; 199:265-285.
34. Hasely LA, Wisnieski JJ, Denburg MR, et al. Antibodies to C1q in SLE: characteristics and relation to Fegamma RIIA alleles. Kidney Int 1997;52:1375-1380.
35. Drug hypersensitivity: a practice parameter. Ann Allergy Asthma Immunol 1999;83:S665-S700.
36. Nicklas RA, Bernstein IL, Li JT, Lee RE, et al. The diagnosis and management of anaphylaxis. J Allergy Clin Immunol 1998;101:S465-S528.
37. Lieberman A. The use of fresh-frozen plasma in hereditary angioedema. JAMA 1994;272:518.
38. Kunschak M, Engl W, Maritsch F, et al. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion; 1998;38:540-549.
39. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 1976;84:580.
40. Greaves M, Lawlor F. Angioedema: manifestations and management. J Am Acad Dermatol 1991;25: 155-161.